News
ULIHF
1.010
NaN%
--
The United Laboratories International Holdings (ULIHF) was downgraded to a Hold Rating at UBS
TipRanks · 4d ago
United Laboratories Wins Novo Milestone for UBT251 Diabetes and Obesity Drug
TipRanks · 09/24 15:08
United Laboratories Wins Acceptance for First-in-China IDegLira Biosimilar Filing
TipRanks · 09/24 11:43
Huatai Securities Remains a Buy on The United Laboratories International Holdings (ULIHF)
TipRanks · 09/09 00:25
United Laboratories Advances UBT251 Into Phase III Diabetes Trials in China
TipRanks · 09/07 13:09
United Laboratories Begins Phase III Dosing of Obesity Drug UBT251 in China
TipRanks · 09/04 11:08
UOB Kay Hian Keeps Their Buy Rating on The United Laboratories International Holdings (ULIHF)
TipRanks · 09/04 00:25
United Laboratories Corrects 2026 Interim Capital Commitments Disclosure
TipRanks · 09/03 12:37
CICC Remains a Buy on The United Laboratories International Holdings (ULIHF)
TipRanks · 09/03 05:06
United Laboratories’ Interim Profit Plunges, Interim Dividend Scrapped
TipRanks · 08/31 15:07
United Laboratories Warns of Sharp First-Half Profit Decline
TipRanks · 08/19 10:39
United Laboratories Schedules Board Meeting to Approve 2026 Interim Results
TipRanks · 08/13 09:20
United Laboratories Wins FDA IND Nod for Novel Obesity and Diabetes Drug
TipRanks · 08/11 10:51
UBS Sticks to Their Buy Rating for The United Laboratories International Holdings (ULIHF)
TipRanks · 07/28 00:26
UBS Reaffirms Their Buy Rating on The United Laboratories International Holdings (ULIHF)
TipRanks · 07/18 00:26
United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251
TipRanks · 07/16 04:07
United Laboratories Wins Approval for New Multi-Dose Eye Drops in China
TipRanks · 07/14 11:39
United Laboratories Wins China Approval for New Tadalafil Men’s Health Drug
TipRanks · 07/02 10:08
United Laboratories Executive Director Fang Yu Ping to Retire After 30 Years of Service
TipRanks · 06/30 10:12
United Laboratories Sets Out Board and Committee Structure
TipRanks · 06/30 10:11
More
Webull provides a variety of real-time ULIHF stock news. You can receive the latest news about United Laboratories International Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ULIHF
United Laboratories International Holdings Ltd is an investment holding company primarily engaged in the pharmaceutical business. The Company operates its business through three segments. The Finished Product segment primarily manufactures and sells insulin products, antibiotic products, ophthalmic products, veterinary drugs and empty capsules. The Bulk Medicine segment mainly sells amoxicillin products. The Intermediate Product segment primarily sells 6-aminopenicillanic acid (6-APA) products and penicillin G potassium products.